Role of protein kinase G in nitric oxide- and cGMP-induced relaxation of newborn ovine pulmonary veins

Journal of Applied Physiology

Volumn 87, Issue 3, 1999, Pages 993-998

  Gao, Yuansheng ^a   Dhanakoti, Srinivas ^a   Tolsa, Jean Francois ^a   Raj, J Usha ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Guanosine 3',5' cylic monophosphate; KT 5720; N 2 (methyl amino)ethyl 5 isoquinolinesulfonamide; N2 etheno 8 bromoguanosine 3',5' monophosphorothioate; Neonatal pulmonary circulation; Vasodilation; phenyl 1

Indexed keywords

8 BROMO CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; ENDOTHELIN 1; KT 5720; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME MECHANISM; FEMALE; LAMB; LUNG CIRCULATION; MALE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY VEIN; VEIN DILATATION; VEIN TONE;

EID: 0032880669     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1999.87.3.993     Document Type: Article

References (44)

1. Abman, S. H., B. A. Chatfield, D. M. Rodman, S. L. Hall, and I. F. McMurtry. Maturational changes in endothelium-derived relaxing factor activity of ovine pulmonary arteries in vitro. Am. J. Physiol. 260 (Lung Cell. Mol. Physiol. 4): L280-L285, 1991.
2. Archer, S. L., J. M. Huang, V. Hampl, D. P. Nelson, P. J. Shultz, and E. K. Weir. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 91: 7583-7587, 1994.
3. Bansal, V., H. Toga, and J. U. Raj. Tone dependent nitric oxide production in ovine vessels in vitro. Respir. Physiol. 93: 249-260, 1993.
4. Bradford, M. M. A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Chem. 72: 249-254, 1973.
5. Butt, E., M. Eigenthaler, and H. G. Genieser. (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. Eur. J. Pharmacol. 269: 265-268, 1994.
6. Butt, E., D. Pohler, H. G. Genieser, J. P. Huggins, and B. Bucher. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS. Br. J. Pharmacol. 116: 3110-3116, 1995.
7. Cassin, S. Role of prostaglandins and thromboxanes in the control of the pulmonary circulation in the fetus and newborn. Semin. Perinatol. 4: 101-107, 1980.
8. Cornfield, D. N., H. L. Reeve, S. Tolarova, E. K. Weir, and S. Archer. Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel. Proc. Natl. Acad. Sci. USA 93: 8089-8094, 1996.
9. Cornwell, T. L., E. Arnold, N. J. Boerth, and T. M. Lincoln. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 267 (Cell Physiol. 36): C1405-C1413, 1994.
10. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J. Biol. Chem. 264: 1146-1155, 1989.
11. Fouty, B., P. Komalavilas, M. Muramatsu, A. Cohen, I. F. McMurtry, T. M. Lincoln, and D. M. Rodman. Protein kinase G is not essential to NO-cGMP modulation of basal tone in rat pulmonary circulation. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H672-H678, 1998.
12. Francis, S. H., and J. D. Corbin. Progress in understanding the mechanism and function of cyclic GMP-dependent protein kinase. In: Advances in Pharmacology. Cyclic GMP: Synthesis, Metabolism, and Function, edited by F. Murad. San Diego, CA: Academic, 1994, vol. 26, p. 115-170.
13. Gamm, D. M., S. H. Francis, T. P. Angelotti, J. D. Corbin, and M. D. Uhler. The type II isoform of cGMP-dependent protein kinase is dimeric and possesses regulatory and catalytic properties distinct from type I isoform. J. Biol. Chem. 270: 27380-27383, 1995.
14. Gao, Y., J. F. Tolsa, and J. U. Raj. Heterogeneity in endothelium-derived nitric oxide-mediated relaxation of different sized pulmonary arteries of newborn lambs. Pediatr. Res. 44: 723-729, 1998.
15. 2. J. Appl. Physiol. 84: 13-18, 1998.
16. 2 cause greater relaxations in pulmonary veins than in arteries of newborn lambs. J. Appl. Physiol. 81: 2534-2539, 1996.
17. Gao, Y., H. Zhou, and J. U. Raj. Endothelium-derived nitric oxide plays a larger role in pulmonary veins than in arteries of newborn lambs. Circ. Res. 76: 559-565, 1995.
18. Gao, Y., H. Zhou, and J. U. Raj. Heterogeneity in role of endothelium-derived NO in pulmonary arteries and veins of full-term fetal lambs. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H1586-H1592, 1995.
19. Garthwaite, J., E. Southam, C. L. Boulton, E. B. Nielsen, K. Schmidt, and B. Mayer. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48: 184-188, 1995.
20. Glass, D. B., and E. G. Krebs. Phosphorylation by guanosine 3',5'-monophosphate-dependent protein kinase of synthetic peptide analogs of a site phosphorylated in histone H2B. J. Biol. Chem. 257: 1196-1200, 1982.
21. ω-nitro-L-arginine on total and segmental vascular resistence in developing lamb lungs. J. Appl. Physiol. 75: 76-85, 1993.
22. Hidaka, H., M. Inagaki, S. Kawamoto, and Y. Sasaki. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23: 5036-5041, 1984.
23. Ignarro, L. J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30: 535-560, 1990.
24. Kase, H., K. Iwahashi, S. Nakanishi, Y. Matsuda, K. Yamada, M. Takahashi, C. Murakata, A. Sato, and M. Kaneko. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142: 436-440, 1987.
25. Lincoln, T. M., and T. L. Cornwell. Intracellular cyclic GMP receptor proteins. FASEB J. 7: 328-338, 1993.
26. Liu, S. F., A. A. Hislop, S. G. Haworth, and P. J. Barnes. Developmental changes in endothelium-dependent pulmonary vasodilation in pigs. Br. J. Pharmacol. 106: 324-338, 1992.
27. Lohmann, S. M., A. B. Vaandrager, A. Smolenski, U. Walter, and H. R. De Jonge. Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem. Sci. 22: 307-312, 1997.
28. Meyer, R. B. J., and J. P. Miller. Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity. Life Sci. 14: 1019-1040, 1974.
29. Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
30. Moore, P., H. Velvis, J. R. Fineman, S. J. Soifer, and M. A. Heymann. EDRF inhibition attenuates the increase in pulmonary blood flow due to oxygen ventilation in fetal lambs. J. Appl. Physiol. 73: 2151-2157, 1992.
31. 5-[imino (nitroamino) methyl]-L-ornithine} impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn Schmiedebergs Arch. Pharmacol. 341: 143-147, 1990.
32. + channels in pulmonary vascular smooth muscle cells: role of nitric oxide. J. Appl. Physiol. 81: 1264-1272, 1996.
33. Pfeifer, A., P. Klatt, S. Massberg, L. Ny, M. Sausbier, C. Hirneiss, G. X. Wang, M. Korth, A. Aszodi, K. E. Andersson, F. Krombach, A. Mayerhofer, P. Ruth, R. Fassler, and F. Hofmann. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J. 17: 3045-3051, 1998.
34. 2 analogue and atrial natriuretic peptide in lambs. Circ. Res. 66: 496-502, 1990.
35. Raj, J. U., and P. Chen. Micropuncture measurement of microvascular pressures in isolated lamb lungs during hypoxia. Circ. Res. 59: 398-404, 1986.
36. Raj, J. U., and P. Chen. Microvascular pressures measured by micropuncture in isolated perfused lamb lungs. J. Appl. Physiol. 61: 2194-2201, 1986.
37. Roskoski, R., Jr. Assay of protein kinase. Methods Enzymol. 99: 3-6, 1983.
38. Sekhar, K. R., R. J. Hatchett, L. Wolfe, S. H. Francis, J. N. Wells, B. B. Jastorff, E. Butt, M. M. Chakinala, and J. D. Corbin. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase. Mol. Pharmacol. 42: 103-108, 1992.
39. Shaul, P. W., M. A. Farrar, and T. M. Zellers. Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H355-H364, 1992.
40. Steinhorn, R. H., F. C. Morin, S. F. Gugino, E. C. Giese, and J. A. Russell. Developmental differences in endothelium-dependent responses in isolated ovine pulmonary arteries and veins. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H2162-H2167, 1993.
41. Toga, H., S. Hibler, B. O. Ibe, and J. U. Raj. Vascular effects of platelet-activating factor in lambs: role of cycle- and lipoxygenase. J. Appl. Physiol. 73: 2559-2566, 1992.
42. Toga, H., B. O. Ibe, and J. U. Raj. In vitro responses of ovine intrapulmonary arteries and veins to endothelin-1. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L15-L21, 1992.
43. Walsh, M. P., G. J. Kargacin, J. Kendrick-Jones, and T. M. Lincoln. Intracellular mechanisms involved in the regulation of vascular smooth muscle tone. Can. J. Physiol. Pharmacol. 73: 565-573, 1995.
44. Wang, Y., and F. Coceani. EDRF in pulmonary resistance vessels from fetal lamb: stimulation by oxygen and bradykinin. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H936-H943, 1994.